Annual report pursuant to Section 13 and 15(d)

Intangible Assets, Net

v3.21.2
Intangible Assets, Net
12 Months Ended
Mar. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangible Assets, Net

Note 6 – Intangible Assets, Net


Intellectual Property


On January 31, 2016, the Company, entered into an IP agreement with HP to acquire a research license to determine the feasibility of incorporating HP’s electro-kinetic display technology in the Company’s products. Under the terms of the agreement, the license is to be used for research purposes only, has a purchase price of $200,000 for the technology and a two-year closing date. On April 12, 2016 the Company and HP entered into the first amendment to the agreement, which reduced the purchase price of the technology to $175,000, of which $75,000 was payable upon completion of the technology transfer and $100,000 was payable upon the first anniversary of the agreement’s effective date. The sales agreement entered into with HP concurrently with the first amendment to the agreement allocated $25,000 of the $200,000 purchase price to acquire equipment to be used in the research. On May 1, 2017, the Company and HP entered into the second amendment to the agreement which increased the purchase price for the technology to $375,000 and extended the closing date to January 31, 2020. Of such $375,000, $75,000 is payable upon completion of the technology transfer, $100,000 is payable upon the first anniversary of the agreement’s effective date, $100,000 is payable upon the second anniversary of the agreement’s effective date and $100,000 is payable upon the third anniversary of the agreement’s effective date. On March 10, 2019, the Company and HP entered into the third amendment to the agreement, which extended the closing date to January 31, 2021, enumerated certain intellectual property owned by HP that is not subject to the exclusive license granted to the Company and revised the schedule of fees payable by the Company to HP, such that $100,000 is payable upon the first anniversary of the agreement’s effective date, $100,000 is payable upon the second anniversary of the agreement’s effective date and $100,000 is payable before April 20, 2019. The parties subsequently agreed that such payment was not due until October 15, 2020. On October 5, 2020, the Company paid $25,000 and the remaining $75,000 was not due until January 21, 2021. Under the terms of the fourth amendment with HP (see details below), the $75,000 will be included in the purchase price for the option to purchase assignable patents, which was paid on February 9, 2021.


Under the guidance of ASC 350, Intangibles – Goodwill and Other Intangibles, the Company recorded the research license at the cost to acquire the license. As of March 31, 2021, the Company has paid $375,000 for the transfer of the technology. The research license will be amortized over a 10-year useful life.


HP Patents


The Intellectual Property Agreement granted the Company an option to purchase the related assignable patents for a purchase price of $1.4 million and must be exercised at least 60 days prior to the closing date of January 31, 2021. The Company will be responsible for all costs associated with the assignable patents and will pay a royalty of 3.0% of the gross revenues received by the Company and its Affiliates for the sale, rental, license or other disposition of the licensed products.


On February 4, 2021, the Company entered into the fourth amendment to the IP agreement with HP. Under the terms of the amendment, the parties agreed to amend the list of patent and patent applications, which includes two additional patents that are assignable to the Company by HP. The Company exercised the option to purchase the assignable patents and paid HP $1.55 million dollars on February 9, 2021. Upon assignment of the patents, the Company will pay HP a royalty fee based on the cumulative gross revenue received by the Company from the patents as follows:


  1. Prior to December 31, 2029:

  Less than $70,000,000, royalty rate of 0.00%

  $70,000,000 - $500,000,000, royalty rate of 1.25%

  $500,000,000 and beyond, royalty rate of 1.00%

  2. After January 1, 2030 and onward, royalty rate of 0.00%

Under the terms of the amendment, HP waived any interest that would have been accrued on the open payable of $75,000 which was due from the Company related to the license agreement dated January 31, 2016.


The carrying amounts related to the intangible assets as of March 31, 2021 and 2020 were as follows:


    March 31,     March 31,  
    2021     2020  
Patents   $ 1,475,000     $ -  
Research license     375,000       375,000  
Total     1,850,000       375,000  
Accumulated amortization     (200,478 )     (139,993 )
Research license, net   $ 1,649,522     $ 235,007  

The following table represents the total estimated amortization of intangible assets for the five succeeding years and thereafter as of March 31, 2021:


    Estimated  
    Amortization  
    Expense  
2022   $ 187,709  
2023     187,709  
2024     188,224  
2025     187,709  
2026     898,171  
Total   $ 1,649,522  

For the years ended March 31, 2021 and 2020, the Company recorded amortization expense of approximately $60,500 and $40,400, respectively.